Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-17 · accession 0001415889-21-004002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-18 | 2021-08-17 | VTGN | SNODGRASS H. RALPH | Pres, CSO | P - Purchase | $2.73 | +3,750 | 34.6K | +12% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | P | A | 3,750 | $2.73 | 34,641 | I By H. Ralph Snodgrass Living Trust, dated 10/2/2008 | — | — | (F1) Includes shares previously held by the Reporting Person directly, but subsequently transferred to the H. Ralph Snodgrass Living Trust, dated 10/2/2008. |